Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenues	$ 206,929	$ 228,640	$ 464,107	$ 416,703
Cost of revenues	(184,021)	(193,304)	(410,061)	(285,517)
Gross profit	22,908	35,336	54,046	131,186
Operating expenses:
Research and development	762,699	2,047,839	1,709,150	3,794,607
General and administrative	890,533	1,382,793	2,125,909	3,924,261
Total operating expenses	1,653,232	3,430,632	3,835,059	7,718,868
Loss from operations	(1,630,324)	(3,395,296)	(3,781,013)	(7,587,682)
Other income (expense):
Foreign currency transaction gain (loss)	3,722	94,900	3,356	(13,393)
Interest expense, net	(60,194)	(214,908)	(163,762)	(426,622)
Research and development incentives	6,209	(26,391)	12,657	136,981
Other income	2,354		43,223
Loss on extinguishment of debt	(393,791)		(393,791)
Change in fair value of convertible debt	460,000		460,000
Total other expense	18,300	(146,399)	(38,317)	(303,034)
Net loss before income taxes	(1,612,024)	(3,541,695)	(3,819,330)	(7,890,716)
Income tax benefit		1,154,935	1,161,197	1,154,935
Net loss applicable to common stockholders	$ (1,612,024)	$ (2,386,760)	$ (2,658,133)	$ (6,735,781)
Basic net loss per share (in Dollars per share)	$ (0.22)	$ (0.83)	$ (0.52)	$ (2.35)
Diluted net loss per share (in Dollars per share)	$ (0.26)	$ (0.83)	$ (0.58)	$ (2.35)
Basic weighted average common shares outstanding (in Shares)	7,246,664	2,867,496	5,092,763	2,864,440
Diluted weighted average common shares outstanding (in Shares)	7,246,664	2,867,496	5,092,763	2,864,440
Contract revenue
Total revenues				$ 50,000
Grant revenue
Total revenues	$ 206,929	$ 228,640	$ 464,107	$ 366,703